Ultrasonographic Measurements of the Median Nerve Before and After Splinting for Carpal Tunnel Syndrome
Completed
- Conditions
- Carpal Tunnel Syndrome
- Registration Number
- NCT02038205
- Lead Sponsor
- University of California, Davis
- Brief Summary
A prospective cohort follow-up study design is undertaken. Both males and females with mild to moderate carpal tunnel syndrome will receive standard-of-care wrist splint for 6 weeks and undergo follow up studies for data collection. Controls will also be seen for a one time visit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 213
Inclusion Criteria
- 18 years or older and;
- Diagnosis of mild to moderate CTS with median motor latency at 8 cm is greater than 4.5 milliseconds or Combined Sensory Index > 0.9 where first line therapy is indicated to include nocturnal wrist bracing
- Control subjects without symptoms of carpal tunnel syndrome.
Exclusion Criteria
- Evidence of severe CTS as seen with electromyographic changes in the body of the muscle
- Untreated hypothyroidism, Rheumatologic disorders
- Diagnosed Severe CTS or Chronic symptoms of carpal tunnel, greater than 1 year, this includes wasting of the hand muscles
- Undergoing or previously treated for carpal tunnel on affected side. This includes surgery (carpal tunnel release), corticosteroid injections, bracing within the last 3 months while wearing the brace consistently every night, or any other intervention.
- Currently pregnant or < 3 months post partum
- History of wrist, hand fracture or severe trauma to affected hand and/or wrist
- Known tumor, mass or deformity of the hand/wrist
- Inflammatory articular disease of the joints or tendons Existing cervical radiculopathy or previous surgeries to the neck for radicular symptoms
- History of electrodiagnostic evidence of generalized polyneuropathy or evidence of denervation
- Diagnosed neuromuscular disorders which may complicate CTS diagnosis
- Implanted electronic device (pacemaker, intrathecal pump/stimulator)
- Any illness that makes it unsafe for the patient to participate in the study
- Not fluent in English as NeuroQOL and other subjective information is limited to the English language interpretation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cross sectional area of median nerve using ultrasound 6 weeks
- Secondary Outcome Measures
Name Time Method Patient-reported outcome measures using NeuroQOL and CTSAQ 6 weeks Motor latency, motor amplitude, sensory velocity and sensory amplitude with electrodiagnostic study 6 weeks cross sectional area, electrodiagnostic study, age, gender, height, weight, BMI, wrist circumference, wrist width. smoking and handedness as predictors of improvement (or no improvement) in the NeuroQOL and CTSAQ-measured clinical severity scale. 6 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie median nerve changes in carpal tunnel syndrome as assessed by ultrasonography?
How does wrist splinting compare to corticosteroid injections in managing mild to moderate carpal tunnel syndrome?
Which biomarkers correlate with median nerve cross-sectional area reduction post-splinting in carpal tunnel syndrome?
What are the long-term adverse effects of continuous wrist splinting for carpal tunnel syndrome management?
Are there combination therapies involving splinting and nerve conduction studies for carpal tunnel syndrome outcomes?
Trial Locations
- Locations (1)
UC Davis Medical Center
🇺🇸Sacramento, California, United States
UC Davis Medical Center🇺🇸Sacramento, California, United States